Targeting Peripheral & Cardiac Metabolism for Therapeutic Benefits in Heart Failure

Time: 8:45 am
day: Day Two


  • Evaluate how the metabolic HFpEF pheno-group is associated with obesity and diabetes and is increasing in prevalence
  • Discover how metabolic therapies such as exercise have shown benefit in HFpEF across multiple trials
  • Learn how targeting dysregulated branched-chain amino acid metabolism has demonstrated efficacy in preclinical HFpEF models